154 related articles for article (PubMed ID: 16762691)
1. Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19.
Gonzalez-Quintela A; García J; Campos J; Perez LF; Alende MR; Otero E; Abdulkader I; Tomé S
Alcohol; 2006 Jan; 38(1):45-9. PubMed ID: 16762691
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of cytokeratin-18 (tissue polypeptide-specific antigen) in liver diseases.
Gonzalez-Quintela A; Mallo N; Mella C; Campos J; Perez LF; Lopez-Rodriguez R; Tome S; Otero E
Liver Int; 2006 Dec; 26(10):1217-24. PubMed ID: 17105587
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of tissue polypeptide specific antigen are correlated with hepatocyte cytokeratin expression in alcoholic liver disease.
Gonzalez-Quintela A; Mella C; Abdulkader I; Perez LF; Campos J; Otero E; Forteza J
Alcohol Clin Exp Res; 2004 Sep; 28(9):1413-8. PubMed ID: 15365314
[TBL] [Abstract][Full Text] [Related]
4. Increased serum tissue polypeptide specific antigen (TPS) in alcoholics: a possible marker of alcoholic hepatitis.
González-Quintela A; Mella C; Pérez LF; Abdulkader I; Caparrini AM; Lojo S
Alcohol Clin Exp Res; 2000 Aug; 24(8):1222-6. PubMed ID: 10968661
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin markers in patients with prostatic diseases.
Wolff JM; Borchers H; Brehmer B; Brauers A; Jakse G
Anticancer Res; 1999; 19(4A):2649-52. PubMed ID: 10470212
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
Kronenberger B; Wagner M; Herrmann E; Mihm U; Piiper A; Sarrazin C; Zeuzem S
J Viral Hepat; 2005 May; 12(3):307-14. PubMed ID: 15850472
[TBL] [Abstract][Full Text] [Related]
7. Significance of cytokeratin markers TPA, TPA (cyk), TPS and CYFRA 21.1 in metastatic disease.
van Dalen A
Anticancer Res; 1996; 16(4B):2345-9. PubMed ID: 8694567
[TBL] [Abstract][Full Text] [Related]
8. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of alcohol consumption and body mass on serum concentrations of cytokeratin-18.
Gonzalez-Quintela A; Tomé S; Fernandez-Merino C; Rey J; Meijide L; Gude F
Alcohol Clin Exp Res; 2011 Dec; 35(12):2202-8. PubMed ID: 21682752
[TBL] [Abstract][Full Text] [Related]
10. Serum sialic acid as a marker of alcohol consumption: effect of liver disease and heavy drinking.
Romppanen J; Punnonen K; Anttila P; Jakobsson T; Blake J; Niemelä O
Alcohol Clin Exp Res; 2002 Aug; 26(8):1234-8. PubMed ID: 12198399
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis.
Tarantino G; Conca P; Coppola A; Vecchione R; Di Minno G
Eur J Clin Invest; 2007 Jan; 37(1):48-53. PubMed ID: 17181567
[TBL] [Abstract][Full Text] [Related]
12. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
13. Serum TNF-alpha levels in relation to alcohol consumption and common TNF gene polymorphisms.
Gonzalez-Quintela A; Campos J; Loidi L; Quinteiro C; Perez LF; Gude F
Alcohol; 2008 Sep; 42(6):513-8. PubMed ID: 18579335
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin fragments in the serum: their utility for the management of oral cancer.
Sawant SS; Zingde SM; Vaidya MM
Oral Oncol; 2008 Aug; 44(8):722-32. PubMed ID: 18203649
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of cytokeratins as tumor markers.
Barak V; Goike H; Panaretakis KW; Einarsson R
Clin Biochem; 2004 Jul; 37(7):529-40. PubMed ID: 15234234
[TBL] [Abstract][Full Text] [Related]
16. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
17. Increased urinary levels of tissue polypeptide specific antigen (TPS) in alcoholics.
Barros P; Gonzalez-Quintela A; Mella C; Perez LF
Anticancer Res; 2006; 26(2B):1531-4. PubMed ID: 16619568
[TBL] [Abstract][Full Text] [Related]
18. Severity of alcohol dependence in decompensated alcoholic liver disease: comparison with heavy drinkers without liver disease and relationship to family drinking history.
Gleeson D; Jones JS; McFarlane E; Francis R; Gellion C; Bradley MP; Peck RJ
Alcohol Alcohol; 2009; 44(4):392-7. PubMed ID: 19286679
[TBL] [Abstract][Full Text] [Related]
19. Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosis.
Sheard MA; Vojtesek B; Simickova M; Valik D
J Cell Biochem; 2002; 85(4):670-7. PubMed ID: 11968007
[TBL] [Abstract][Full Text] [Related]
20. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
Koivisto H; Hietala J; Niemelä O
Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
